High-dose chemotherapy with autologous stem cell rescue as first line of treatment in young children with medulloblastoma and supratentorial primative neuroectodermal tumors

Journal of Neuro-Oncology

Volumn 67, Issue 1-2, 2004, Pages 101-106

  Pérez Martínez, Antonio ^a   Quintero, Victor ^a   González Vincent, Marta ^a   Sevilla, Julián ^a   Díaz, Miguel Ángela ^a   Madero, Luis ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Autologous peripheral blood progenitor cell transplantation; High dose chemotherapy; Medulloblastoma; Supratentorial primitive neuroectodermal tumors; Young children

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BUSULFAN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; PROCARBAZINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA; TOPOTECAN; VINCRISTINE;

ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BACTERIAL INFECTION; BLOOD TRANSFUSION; BONE MARROW SUPPRESSION; BRAIN TUMOR; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOPRESERVATION; DISEASE ACTIVITY; DRUG ERUPTION; DRUG MEGADOSE; DRUG RESPONSE; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; MALE; MEDULLOBLASTOMA; MORTALITY; MYCOSIS; NEUROECTODERM TUMOR; PERIPHERAL BLOOD STEM CELL; PRESCHOOL CHILD; STEM CELL MOBILIZATION;

ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BUSULFAN; CEREBELLAR NEOPLASMS; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; MALE; MEDULLOBLASTOMA; MELPHALAN; NEUROECTODERMAL TUMORS, PRIMITIVE; STEM CELL TRANSPLANTATION; SUPRATENTORIAL NEOPLASMS; THIOTEPA; TOPOTECAN; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 1842589315     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NEON.0000021774.79094.25     Document Type: Article

References (22)

1. Allon JC, Epstein F: Medulloblastoma and other primary malignant neuroectodermal tumor of the CNS: the effect of age and the patients extent of disease on prognosis. J Neurosurg 57: 446-451, 1982
2. Zeltzer P, Boyett J, Finlay J, Albright A, Rorke L, Milstein J, Allen J, Stevens K, Stanley P, Li H, Wisoff J, Geyer R, McGuire-Cullen P, Stehbens J, Shurin S, Packer R: Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 17: 832-845, 1999
3. Dunkel IJ, Finlay JL: High-dose chemotherapy with autologous stem cell rescue for brain tumors. Crit Rev Oncol Hematol 41: 197-204, 2002
4. Graham ML, Herndon JE II, Casey JR, Chaffee S, Ciocci GH, Krischer JP, Kurtzberg J, Laughlin MJ, Longee DC, Olson JF, Paleologus N, Pennington CN, Friedman HS: High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high risk pediatric brain tumors. J Clin Oncol 15: 1814-1823, 1997
5. Kalifa C, Valteau D, Pizer B, Vassal G, Grill J, Hartmann O: High-dose chemotherapy in childhood brain tumours. Child's Nerv Syst 15: 498-505, 1999
6. Jenkin D, Danjoux C, Greenberg M: Subsequent quality of life for children irradiated for a brain tumor before age four years. Med Pediatr Oncol 31: 506-511, 1998
7. Mason WP, Grovas A, Halpern S, Dunkel IJ, Garvin J, Heller G, Rosenblum M, Gardner S, Lyden D, Sands S, Puccetti D, Lindsley K, Merchant TE, O'Malley B, Bayer L, Petriccione MM, Allen J, Finlay JL: Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. J Clin Oncol 16: 210-221, 1998
8. Finlay JL, Grovas Am, Garvin J, Dunkel I, Bayer L, Pucetti D, Halpern S, Drachtman R, Goldman S, Tugal O, Jayabose S, Weinblatt M, Sadhev I, Allen JC: The 'head start' regimen for children less than 6 years of age newly-diagnosed with malignant brain tumors. Med Pediatr Oncol 25: 250 (# O-69), 1995
9. Marec-Berare P, Jouvet A, Thiesse P, Kalifa C, Koz F, Frappaz D: Supratentorial embryonal tumors in children under 5 years of age: an SFOP study of treatment with postoperative chemotherapy alone. Med Pediatr Oncol 38: 83-90, 2002
10. Laurent J, Chang CH, Cohen M: A classification system for primitive neuroectodermal tumors (medulloblastoma) of the posterior fossa. Cancer 56: 1807-1809, 1985
11. Lansky SB, List MA, Lansky LL, Ritter-Sterr C, Miller D: The measurement of performance in childhood cancer patients. Cancer 60: 1651-1656, 1987
12. Sevilla J, Gonzalez-Vicent M, Madero L, García-Sanchez F, Diaz MA: Granulocyte colony-stimulating factor alone at 12 μg/kg twice a day for 4 days for peripheral blood progenitor cell priming in pediatric patients. Bone Marrow Transplant 30: 417-420, 2002
13. Trotti A, Byhardt R, Stetz J, Gwede C, Corn B, Fu K, Gunderson L, McCormick B, Morrisintegral M, Rich T, Shipley W, Curran W: Common toxicity criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: impact of radiotherapy. Int J Radiat Oncol Biol Phys 47: 13-47, 2000
14. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 3: 457-481, 1958
15. Madero L, Vicent MG, Sevilla J, Prudencio M, Rodríguez F, Díaz MA: Engraftment syndrome in children undergoing autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant 30: 355-358, 2002
16. Mulhern R, Kepner J, Thomas P, Armstrong F, Friedman H, Kun L: Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to received conventional or reduced-dose craniospinal irradiation: A Pediatric Oncologic Group study. J Clin Oncol 16: 1723-1728, 1998
17. Guruangan S, Dunkel IJ, Goldman S, Garvin JH, Rosenblum M, Boyett JM, Gardner S, Merchant TE, Gollamudi S, Finlay JL: Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors. J Clin Oncol 16: 2486-2493, 1998
18. Pinkerton Cr: ENSG 1-randomised study of high-dose melphalan in neuroblastoma. Bone Marrow Transplant 7(Suppl 3): 112-113, 1991
19. Meyers PA, Gorlick R, Heller G, Casper E, Lane J, Huvos AG, Healey JH: Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. J Clin Oncol 16: 2452-2458, 1998
20. Schmandt S, Kühl J: Chemotherapy as prophylaxis and treatment of meningosis in children less than 3 years of age with medulloblastoma. J Neuro-Oncol 38: 187-192, 1998
21. Díaz MA, Vicent MG, Madero L: High-dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors. Bone Marrow Transplant 11: 1157-1159, 1999
22. Kalifa C, Hartmann O, Demeocq F, Vassal G, Couanet D, Terrier-Lacombe MJ, Valteau D, Brugieres L, Lemerle J: High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study. Bone Marrow Transplant 9: 227-233, 1992